Dalrymple's sign
Dalrymple's sign is a medical term referring to the abnormal widening of the palpebral fissure, or the opening between the eyelids, often associated with Graves' disease. This sign is named after British physician, John Dalrymple, who first described it in the 19th century.
Overview[edit | edit source]
Dalrymple's sign is characterized by an abnormal widening of the palpebral fissure, which is the opening between the upper and lower eyelids. This condition is often associated with Graves' disease, an autoimmune disorder that results in the overproduction of thyroid hormones, or hyperthyroidism.
Symptoms[edit | edit source]
The primary symptom of Dalrymple's sign is the abnormal widening of the palpebral fissure. This can result in the white part of the eye, or the sclera, being visible above and below the iris when the eyes are in a normal position. Other symptoms may include exophthalmos, or bulging of the eyes, and lid lag, a delay in the movement of the eyelid when the eye moves downward.
Causes[edit | edit source]
The main cause of Dalrymple's sign is Graves' disease. This autoimmune disorder causes the body's immune system to attack the thyroid gland, leading to an overproduction of thyroid hormones. These hormones can cause a variety of symptoms, including the abnormal widening of the palpebral fissure seen in Dalrymple's sign.
Diagnosis[edit | edit source]
Diagnosis of Dalrymple's sign is typically made through a physical examination of the eyes. The doctor may also order blood tests to check for the presence of thyroid hormones and antibodies associated with Graves' disease.
Treatment[edit | edit source]
Treatment for Dalrymple's sign typically involves addressing the underlying cause, which is often Graves' disease. This may involve medication to reduce the production of thyroid hormones, radioactive iodine therapy, or surgery to remove part or all of the thyroid gland.
See also[edit | edit source]
Dalrymple's sign Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD